Free Trial

Aditxt (ADTX) Competitors

Aditxt logo
$1.16 -0.01 (-0.86%)
As of 10:52 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

ADTX vs. TLPH, LSB, AEON, DWTX, JBIO, CHRO, CLRB, BMRA, KPRX, and TSBX

Should you be buying Aditxt stock or one of its competitors? The main competitors of Aditxt include Talphera (TLPH), LakeShore Biopharma (LSB), AEON Biopharma (AEON), Dogwood Therapeutics (DWTX), Jade Biosciences (JBIO), Chromocell Therapeutics (CHRO), Cellectar Biosciences (CLRB), Biomerica (BMRA), Kiora Pharmaceuticals (KPRX), and Turnstone Biologics (TSBX). These companies are all part of the "pharmaceutical products" industry.

Aditxt vs. Its Competitors

Talphera (NASDAQ:TLPH) and Aditxt (NASDAQ:ADTX) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, institutional ownership, risk, profitability and earnings.

In the previous week, Aditxt had 2 more articles in the media than Talphera. MarketBeat recorded 3 mentions for Aditxt and 1 mentions for Talphera. Talphera's average media sentiment score of 1.89 beat Aditxt's score of 0.76 indicating that Talphera is being referred to more favorably in the media.

Company Overall Sentiment
Talphera Very Positive
Aditxt Positive

Talphera has a net margin of 0.00% compared to Aditxt's net margin of -46,082.47%. Talphera's return on equity of -130.28% beat Aditxt's return on equity.

Company Net Margins Return on Equity Return on Assets
TalpheraN/A -130.28% -59.25%
Aditxt -46,082.47%-389.10%-84.71%

Talphera has a beta of -0.11, indicating that its stock price is 111% less volatile than the S&P 500. Comparatively, Aditxt has a beta of 1.49, indicating that its stock price is 49% more volatile than the S&P 500.

Talphera has higher revenue and earnings than Aditxt.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Talphera$650K13.06-$13M-$0.45-0.92
Aditxt$55.32K44.26-$34.45MN/AN/A

37.7% of Talphera shares are owned by institutional investors. Comparatively, 15.5% of Aditxt shares are owned by institutional investors. 3.2% of Talphera shares are owned by insiders. Comparatively, 0.0% of Aditxt shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Talphera currently has a consensus price target of $5.00, indicating a potential upside of 1,107.73%. Given Talphera's stronger consensus rating and higher probable upside, analysts clearly believe Talphera is more favorable than Aditxt.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Talphera
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
2 Strong Buy rating(s)
3.50
Aditxt
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Talphera beats Aditxt on 12 of the 15 factors compared between the two stocks.

Get Aditxt News Delivered to You Automatically

Sign up to receive the latest news and ratings for ADTX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ADTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ADTX vs. The Competition

MetricAditxtMED IndustryMedical SectorNASDAQ Exchange
Market Cap$2.45M$2.43B$5.56B$9.28B
Dividend YieldN/A1.79%4.23%4.03%
P/E RatioN/A9.2128.6419.62
Price / Sales44.26691.60430.8295.68
Price / CashN/A164.3436.0257.93
Price / Book-0.764.648.155.59
Net Income-$34.45M$30.99M$3.24B$257.73M
7 Day Performance-4.55%0.13%-0.64%-0.23%
1 Month Performance-16.30%7.35%4.92%7.98%
1 Year Performance-99.99%-6.60%25.99%13.16%

Aditxt Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ADTX
Aditxt
N/A$1.16
-0.9%
N/A-100.0%$2.45M$55.32K0.0060News Coverage
Gap Down
TLPH
Talphera
2.3684 of 5 stars
$0.46
+2.7%
$5.00
+979.9%
-52.5%$9.49M$650K-1.0319
LSB
LakeShore Biopharma
0.7237 of 5 stars
$0.99
-0.4%
N/A-76.1%$9.22M$672.27M0.00773Gap Down
AEON
AEON Biopharma
2.4121 of 5 stars
$0.79
-5.5%
$360.00
+45,371.8%
-99.5%$8.95MN/A4.405
DWTX
Dogwood Therapeutics
1.8774 of 5 stars
$4.60
-4.2%
$10.00
+117.4%
N/A$8.79MN/A-0.255
JBIO
Jade Biosciences
2.2888 of 5 stars
$10.45
-6.2%
$14.00
+34.0%
N/A$8.78MN/A-0.1820Analyst Forecast
CHRO
Chromocell Therapeutics
N/A$1.34
+6.3%
N/A-88.5%$8.69MN/A-1.084Gap Up
High Trading Volume
CLRB
Cellectar Biosciences
2.5398 of 5 stars
$4.80
flat
$375.00
+7,712.5%
-93.8%$8.69MN/A-0.2210Positive News
BMRA
Biomerica
1.4977 of 5 stars
$3.40
+4.0%
N/A+4.3%$8.67M$5.41M-1.4760
KPRX
Kiora Pharmaceuticals
3.1737 of 5 stars
$2.81
-1.4%
$10.00
+255.9%
-27.9%$8.54M$16.02M-0.9710
TSBX
Turnstone Biologics
3.3932 of 5 stars
$0.37
+0.9%
$0.45
+23.3%
-85.8%$8.45M$19.31M-0.1382

Related Companies and Tools


This page (NASDAQ:ADTX) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners